| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.80▼ | 1.79▼ | 1.80▼ | 1.45▲ | 1.30▲ |
| MA10 | 1.79▼ | 1.80▼ | 1.75▲ | 1.27▲ | 1.42▲ |
| MA20 | 1.80▼ | 1.69▲ | 1.56▲ | 1.25▲ | 1.56▲ |
| MA50 | 1.66▲ | 1.41▲ | 1.30▲ | 1.42▲ | 1.02▲ |
| MA100 | 1.43▲ | 1.27▲ | 1.25▲ | 1.53▲ | 1.63▲ |
| MA200 | 1.28▲ | 1.25▲ | 1.32▲ | 1.07▲ | 5.64▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.016▼ | -0.011▼ | 0.015▲ | 0.083▲ | -0.054▼ |
| RSI | 50.189▲ | 57.740▲ | 63.860▲ | 72.322▲ | 57.567▲ |
| STOCH | 45.804 | 41.530 | 63.008 | 61.207 | 19.608▼ |
| WILL %R | -92.308▼ | -68.750 | -36.667 | -23.146▲ | -58.857 |
| CCI | -78.932 | -28.293 | 46.998 | 228.481▲ | 8.340 |
|
Wednesday, May 06, 2026 08:25 AM
Company Advances to Active Clinical Execution, Supporting Potential Accelerated Path Toward Regulatory Authorization ATLANTA, GA - May 6, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a ...
|
|
Wednesday, April 29, 2026 06:45 AM
Near-Term Clinical Milestones and Combination Strategy Position Program for Next Stage of Value Creation ATLANTA, GA - April 29, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a ...
|
|
Wednesday, April 15, 2026 08:07 AM
Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/05/26 | 1.85 | 1.90 | 1.74 | 1.76 | 881,480 |
| 06/05/26 | 1.435 | 2.00 | 1.38 | 1.65 | 1,401,920 |
| 05/05/26 | 1.28 | 1.48 | 1.2601 | 1.42 | 496,591 |
| 04/05/26 | 1.15 | 1.28 | 1.11 | 1.27 | 359,008 |
| 01/05/26 | 1.08 | 1.51 | 1.08 | 1.155 | 4,284,436 |
| 30/04/26 | 1.01 | 1.11 | 1.00 | 1.09 | 63,773 |
| 29/04/26 | 1.10 | 1.11 | 0.9631 | 1.05 | 195,288 |
| 28/04/26 | 1.12 | 1.1401 | 1.10 | 1.10 | 88,374 |
| 27/04/26 | 1.12 | 1.14 | 1.10 | 1.11 | 36,097 |
| 24/04/26 | 1.13 | 1.14 | 1.09 | 1.09 | 66,157 |
|
|
||||
|
|
||||
|
|